Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Etablering af det glykæmiske indeks for frugtdrikke ved hjælp af forskellige målemetoder

17. september 2026 opdateret af: Emma Greatorex Brooks, University of Bath

Undersøgelse for at undersøge glykæmiske reaktioner på indtagelse af frugtsaft og smoothies ved hjælp af forskellige målemetodologier.

Glycaemic responses to carbohydrates ingested as fruit sugars may vary depending on factors inherent to the fruit and the type of sugar. The aim of this project is to investigate the glycaemic responses to a range of commercially available fruit drinks and to establish the glycaemic index for each product relative to a glucose reference. Differences in recorded responses could also be influenced by the sample type (capillary blood vs interstitial fluid) and participant characteristics. Participants will ingest 8 test drinks including 5 different fruit drinks (OJ, AJ, S&B, ENERGISE, BLUE), each matched for carbohydrate to the glucose reference (CONTROL) which will be sampled two times, an additional sample of one of the smoothies (S&B) will also be replicated. Fingerstick capillary blood sampling alongside dual sited continuous glucose monitors (CGM) will measure glucose and lactate concentrations, subjective appetite sensations will also be recorded. The tests will follow best practice guidelines for glycaemic index testing. These data will provide insight into how differing formulations can alter the glycaemic responses to fruit drinks, and whether sampling technique can affect the interpretations of measurement.

Studieoversigt

Status

Afsluttet

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

11

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Age: 18-65 years
  • Body mass index 18-30 kg/m2

Exclusion Criteria:

  • diagnosis of any form of diabetes
  • intolerances or allergies to any of the study procedures (e.g. fructose/inulin intolerance)
  • Fructose malabsorption
  • Inborn errors of fructose metabolism (e.g. fructokinase deficiency, aldolase B deficiency, fructose-1,6-bisphosphatase deficiency)
  • pregnant or lactating
  • any condition that could introduce bias to the study (e.g. diagnoses of lipid disorders, including cardiovascular disease, or therapies that alter lipid or glucose metabolism, such as statins or niacin).

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Grundvidenskab
  • Tildeling: Randomiseret
  • Interventionel model: Crossover opgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: CONTROL

50 g glucose (55 g dextrose powder accounting for hydration) plus 641 mL water

Commercially available fruit drinks or smoothies

Aktiv komparator: REPLICATE CONTROL

50 g glucose (55 g dextrose powder accounting for hydration) plus 641 mL water

Commercially available fruit drinks or smoothies

Eksperimentel: S&B

417 mL of commercially available "Strawberries & Bananas" fruit smoothie providing 50 g carbohydrate [strawberries (31%), apples, bananas (22%), white grapes, oranges, blackcurrants]. Plus 224 mL water to standardise volume

Commercially available fruit drinks or smoothies

Eksperimentel: REPLICATE S&B

417 mL of commercially available "Strawberries & Bananas" fruit smoothie providing 50 g carbohydrate [strawberries (31%), apples, bananas (22%), white grapes, oranges, blackcurrants]. Plus 224 mL water to standardise volume

Commercially available fruit drinks or smoothies

Eksperimentel: OJ

641 mL of commercially available "Smooth Orange Juice" providing 50 g of carbohydrate [100% oranges]

Commercially available fruit drinks or smoothies

Eksperimentel: AJ

455 mL commercially available "Apple Juice" providing 50 g of carbohydrate [apples, ascorbic acid]. Plus 186 mL water to standardise volume

Commercially available fruit drinks or smoothies

Eksperimentel: ENERGISE

417 mL of commercially available "Energise Super Smoothie" providing 50 g carbohydrate [apples (50%), red grapes, bananas, strawberries (10%), blackcurrants, sour cherries (3.3%), pressed beetroot, flax seeds (0.56%), guarana infusion (0.01%), vitamins B1, B2, B3, B6, C & E]. Plus 224 mL water to standardise volume

Commercially available fruit drinks or smoothies

Eksperimentel: BLUE

521 mL of commercially available "Bolt from the Blue" juice drink providing 50 g carbohydrate [apple (66%), coconut water (18%), white grapes, white guava (5.2%), passion fruit, lime (0.87%), spirulina extract (0.81%) vitamins B1, B2, B3, B6, C & E]. Plus 120 mL water to standardise volume

Commercially available fruit drinks or smoothies

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Glycaemic indices for 5 test drinks measured using capillary blood samples
Tidsramme: 120 minutes

Glycaemic indices [2-hour incremental area under the glucose curve (mmol/L-1x120 minutes) for each of the 5 test drinks relative to mean value of control conditions (CONTROL, REPLICATE CONTROL), expressed as a percentage] in capillary blood samples

120 minutes

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Glycaemic index of all conditions with capillary blood samples vs CGM
Tidsramme: 120 minutes

The difference in glycaemic index [2-hour incremental area under the glucose curve (mmol/L-1x120 minutes) for 5 test drinks relative to mean control (CONTROL, REPLICATE CONTROL), expressed as a percentage] in capillary blood samples versus continuous glucose monitors.

120 minutes

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Comparisons between conditions in glucose concentration in capillary samples
Tidsramme: 120 minutes

Comparison of blood glucose concentration 2-hour incremental area under the curve (iAUC) min.mmol/L between test conditions

120 minutes
Comparisons between conditions in glucose concentration in capillary samples
Tidsramme: 120 minutes

Comparison of postprandial peak concentration mmol/L of blood glucose between test conditions (Cmax)

120 minutes
Comparisons between conditions in glucose concentration in capillary samples
Tidsramme: 120 minutes

Comparison of time to peak blood glucose concentration in minutes (Tmax) between test conditions

120 minutes
Comparisons between conditions in glucose concentration in capillary samples
Tidsramme: 120 minutes

Comparison of blood glucose concentration mmol/L at 2 hours between test conditions

120 minutes
Comparisons between conditions in glucose concentration with CGM
Tidsramme: 120 minutes

Comparison of glucose concentration 2-hour incremental area under the curve (iAUC) min.mmol/L between test conditions

120 minutes
Comparisons between conditions in glucose concentration with CGM
Tidsramme: 120 minutes

Comparison of postprandial peak concentration mmol/L of glucose between test conditions (Cmax)

120 minutes
Comparisons between conditions in glucose concentration with CGM
Tidsramme: 120 minutes

Comparison of time to peak glucose concentration in minutes (Tmax) between test conditions

120 minutes
Comparisons between conditions in glucose concentration with CGM
Tidsramme: 120 minutes

Comparison of glucose concentration mmol/L at 2 hours between test conditions

120 minutes
Comparisons between conditions in lactate concentration in capillary samples
Tidsramme: 120 minutes

Comparison of blood lactate concentration 2-hour incremental area under the curve (iAUC) min.mmol/L between test conditions

120 minutes
Comparisons between conditions in lactate concentration in capillary samples
Tidsramme: 120 minutes

Comparison of postprandial peak concentration mmol/L of blood lactate between test conditions (Cmax)

120 minutes
Comparisons between conditions in lactate concentration in capillary samples
Tidsramme: 120 minutes

Comparison of time to peak blood lactate concentration in minutes (Tmax) between test conditions

120 minutes
Comparisons between conditions in lactate concentration in capillary samples
Tidsramme: 120 minutes

Comparison of blood lactate concentration mmol/L at 2 hours between test conditions

120 minutes
Comparisons between conditions of appetite ratings
Tidsramme: 120 minutes

Comparison of subjective appetite sensations assessed with visual analogue scales (2-hour area under the curve min.mmVAS)

120 minutes
Comparisons between individuals
Tidsramme: 120 minutes

Comparison of Postprandial lactate concentration min.mmol/L between individuals 2-hour incremental area under curve (iAUC)

120 minutes
Comparisons between individuals
Tidsramme: 120 minutes

Comparison of Postprandial glucose concentration min.mmol/L between individuals 2-hour incremental area under curve (iAUC)

120 minutes
Comparisons between individuals
Tidsramme: 120 minutes

Comparison of Appetite rating responses min.mmVAS between individuals 2-hour area under curve (AUC)

120 minutes
Comparisons within individuals
Tidsramme: 120 minutes

Comparison within individuals of interstitial glucose concentrations measurements from continuous glucose monitors on left and right arms.

120 minutes

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

13. marts 2025

Primær færdiggørelse (Faktiske)

9. juli 2025

Studieafslutning (Faktiske)

9. juli 2025

Datoer for studieregistrering

Først indsendt

28. februar 2025

Først indsendt, der opfyldte QC-kriterier

20. marts 2025

Først opslået (Faktiske)

27. marts 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 7134-9931

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified data will be made available open access on the University of Bath Research Data Archive (RDA) at the point of publication in a peer-reviewed journal.

IPD-delingstidsramme

These will become available at the point of publication permanently

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP
  • ICF

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner